Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: lindend who wrote (886)	6/3/1998 11:47:00 AM
From: Bill Wexler	Read Replies (4) \| Respond to of 4634

Zonagen admits that Vasomax is ineffective. Yesterday, the company announced the following... ...The company said in a statement that 51 percent of patients taking oral phentolamine, or Vasomax, were able to achieve penetration 75 percent of the time on a dose of 40 mg. The company said 53 percent of patients taking an 80 mg dose achieved penetration 75 percent of the time. Thirty-eight percent of patients taking a placebo were able to achieve penetration 75 percent of the time... I stand by my claim that Zonagern is a fraud and a scam. Zonagen has a history of similar fraud, most recently with Immumax. I stand by my prediction that Zonagen will eventually collapse.